I Asked Bill Gates What's The Next Crisis?

Bill Gates argues the next major catastrophe is more likely to be a highly infectious virus than a war—and warns that the world still hasn’t built the systems needed to stop such outbreaks early. He points to the pattern of respiratory viruses that periodically emerge with high transmissibility and cause fatalities, noting that these pathogens spread while people are still moving through everyday life (planes, buses, workplaces). In his view, the failure to prepare wasn’t a lack of foresight so much as a budgeting problem: pandemics arrive too irregularly for governments and institutions to treat them like an always-on risk, so “insurance” against epidemics gets underfunded.

Gates frames the cost of prevention as relatively small compared with the scale of potential loss, comparing pandemic risk to other hazards—earthquakes, fires, hurricanes—that people remember because they recur more predictably. Pandemics, by contrast, can lull societies into complacency. He also expands the threat beyond naturally occurring outbreaks, warning that bioterrorism—engineered viruses designed to cause damage—raises the probability of severe events beyond what would be expected from natural epidemics alone.

On what preparedness should look like, Gates divides the work into two tracks: field readiness and research-and-development. In R&D, he calls for faster vaccine platforms and manufacturing that can scale globally—specifically mRNA improvements that enable quicker production, cheaper output, and thermal stability. He also highlights therapeutics such as antibodies and diagnostics that can run at massive scale, including the ability to perform around 10 million PCR tests per day. In the field, he emphasizes widespread diagnostic equipment, trained epidemiology teams, and a constant flow of information so outbreaks can be detected and contained before they spread broadly.

A major thread running through the conversation is how societies decide what is true during health crises. Gates says the internet has created a “golden age” for learning facts, but social media also accelerates misinformation through labeling and moderation challenges that are still not well solved. He argues for expertise-driven rules that reduce the spread of falsehoods without turning the system into a profit-driven free-for-all—especially because misinformation can directly affect vaccination uptake and prolong epidemics.

The discussion turns to a specific controversy about vaccine development and manufacturing. Gates rejects the idea that vaccine production should be treated like open-source software, arguing that vaccine factories require exquisite quality control and can be shut down for months if standards slip. He says the Oxford vaccine effort needed phase three trial capacity and manufacturing expertise that Oxford alone couldn’t provide, with AstraZeneca stepping in and working with non-profit goals. He also addresses vaccine rollout constraints as a three-part problem: supply, logistics, and demand, expressing hope for approvals of Johnson and Johnson’s single-dose vaccine and additional options such as AstraZeneca and Novovax for the developing world.

Overall, the core message is that pandemic risk is foreseeable and recurring, but preparedness fails when societies underinvest in scalable diagnostics, manufacturing, and information systems—then get blindsided when a transmissible respiratory virus arrives.